{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:29:00Z","timestamp":1777627740701,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-734","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T03:11:52Z","timestamp":1412133112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The basal epithelial marker P-cadherin associates with breast cancer cell populations harboring a glycolytic and acid-resistant phenotype"],"prefix":"10.1186","volume":"14","author":[{"given":"B\u00e1rbara","family":"Sousa","sequence":"first","affiliation":[]},{"given":"Ana Sofia","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Ana Rita","family":"Nobre","sequence":"additional","affiliation":[]},{"given":"Nair","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Diana","family":"Martins","sequence":"additional","affiliation":[]},{"given":"C\u00e9line","family":"Pinheiro","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9 Filipe","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9","family":"Albergaria","sequence":"additional","affiliation":[]},{"given":"Ren\u00e9","family":"Gerhard","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Baltazar","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Paredes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"4912_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1210\/endo-83-4-706","volume":"83","author":"JM Yochim","year":"1968","unstructured":"Yochim JM, Mitchell JA: Intrauterine Oxygen Tension in the Rat During Progestation: Its Possible Relation to Carbohydrate Metabolism and the Regulation of Nidation. Endocrinology. 1968, 83: 706-713. 10.1210\/endo-83-4-706.","journal-title":"Endocrinology"},{"key":"4912_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.stem.2010.07.007","volume":"7","author":"A Mohyeldin","year":"2010","unstructured":"Mohyeldin A, Garzon-Muvdi T, Quinones-Hinojosa A: Oxygen in stem cell biology: a critical component of the stem cell niche. Cell stem cell. 2010, 7: 150-161. 10.1016\/j.stem.2010.07.007.","journal-title":"Cell stem cell"},{"key":"4912_CR3","first-page":"2361","volume":"2013","author":"NM Vacanti","year":"1830","unstructured":"Vacanti NM, Metallo CM: Exploring metabolic pathways that contribute to the stem cell phenotype. Biochim Biophys Acta. 1830, 2013: 2361-2369.","journal-title":"Biochim Biophys Acta"},{"key":"4912_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB: Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012, 21: 297-308. 10.1016\/j.ccr.2012.02.014.","journal-title":"Cancer Cell"},{"key":"4912_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ng.2471","volume":"45","author":"K Birsoy","year":"2013","unstructured":"Birsoy K, Wang T, Possemato R, Yilmaz OH, Koch CE, Chen WW, Hutchins AW, Gultekin Y, Peterson TR, Carette JE, Brummelkamp TR, Clish CB, Sabatini DM: MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat Genet. 2013, 45: 104-108.","journal-title":"Nat Genet"},{"key":"4912_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003, 3: 721-732. 10.1038\/nrc1187.","journal-title":"Nat Rev Cancer"},{"key":"4912_CR7","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1007\/s00018-007-7390-6","volume":"64","author":"K Lundgren","year":"2007","unstructured":"Lundgren K, Holm C, Landberg G: Hypoxia and breast cancer: prognostic and therapeutic implications. Cell Mol Life Sci. 2007, 64: 3233-3247. 10.1007\/s00018-007-7390-6.","journal-title":"Cell Mol Life Sci"},{"key":"4912_CR8","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1371\/journal.pmed.0030047","volume":"3","author":"JT Chi","year":"2006","unstructured":"Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A, Wang Y, Kristensen GB, Helland A, Borresen-Dale AL, Giaccia A, Longaker MT, Hastie T, Yang GP, van de Vijver MJ, Brown PO: Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med. 2006, 3: e47-10.1371\/journal.pmed.0030047.","journal-title":"PLoS Med"},{"key":"4912_CR9","doi-asserted-by":"publisher","first-page":"e1000293","DOI":"10.1371\/journal.pgen.1000293","volume":"4","author":"JL Chen","year":"2008","unstructured":"Chen JL, Lucas JE, Schroeder T, Mori S, Wu J, Nevins J, Dewhirst M, West M, Chi JT: The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet. 2008, 4: e1000293-10.1371\/journal.pgen.1000293.","journal-title":"PLoS Genet"},{"key":"4912_CR10","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1186\/bcr2899","volume":"13","author":"ML Gatza","year":"2011","unstructured":"Gatza ML, Kung HN, Blackwell KL, Dewhirst MW, Marks JR, Chi JT: Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes. Breast Cancer Res. 2011, 13: R62-10.1186\/bcr2899.","journal-title":"Breast Cancer Res"},{"key":"4912_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00428-010-0938-0","volume":"457","author":"CL Chen","year":"2010","unstructured":"Chen CL, Chu JS, Su WC, Huang SC, Lee WY: Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX. Virchows Arch. 2010, 457: 53-61. 10.1007\/s00428-010-0938-0.","journal-title":"Virchows Arch"},{"key":"4912_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1365-2559.2010.03560.x","volume":"56","author":"C Pinheiro","year":"2010","unstructured":"Pinheiro C, Albergaria A, Paredes J, Sousa B, Dufloth R, Vieira D, Schmitt F, Baltazar F: Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology. 2010, 56: 860-867. 10.1111\/j.1365-2559.2010.03560.x.","journal-title":"Histopathology"},{"key":"4912_CR13","first-page":"1279","volume":"26","author":"C Pinheiro","year":"2011","unstructured":"Pinheiro C, Sousa B, Albergaria A, Paredes J, Dufloth R, Vieira D, Schmitt F, Baltazar F: GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression. Histol Histopathol. 2011, 26: 1279-1286.","journal-title":"Histol Histopathol"},{"key":"4912_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/sj.bjc.6604844","volume":"100","author":"EY Tan","year":"2009","unstructured":"Tan EY, Yan M, Campo L, Han C, Takano E, Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EK, O'Toole SA, McNeil CM, Crea P, Segara D, Sutherland RL, Harris AL, Fox SB: The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br J Cancer. 2009, 100: 405-411. 10.1038\/sj.bjc.6604844.","journal-title":"Br J Cancer"},{"key":"4912_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ccr.2013.01.022","volume":"23","author":"C Dong","year":"2013","unstructured":"Dong C, Yuan T, Wu Y, Wang Y, Fan Teresa WM, Miriyala S, Lin Y, Yao J, Shi J, Kang T, Lorkiewicz P, St Clair D, Hung MC, Evers BM, Zhou BP: Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer. Cancer Cell. 2013, 23: 316-331. 10.1016\/j.ccr.2013.01.022.","journal-title":"Cancer Cell"},{"key":"4912_CR16","doi-asserted-by":"publisher","first-page":"5812","DOI":"10.1158\/0008-5472.CAN-12-1098","volume":"72","author":"ML McCleland","year":"2012","unstructured":"McCleland ML, Adler AS, Shang Y, Hunsaker T, Truong T, Peterson D, Torres E, Li L, Haley B, Stephan JP, Belvin M, Hatzivassiliou G, Blackwood EM, Corson L, Evangelista M, Zha J, Firestein R: An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer. Cancer Res. 2012, 72: 5812-5823. 10.1158\/0008-5472.CAN-12-1098.","journal-title":"Cancer Res"},{"key":"4912_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s00330-013-3037-1","volume":"24","author":"HR Koo","year":"2014","unstructured":"Koo HR, Park JS, Kang KW, Cho N, Chang JM, Bae MS, Kim WH, Lee SH, Kim MY, Kim JY, Seo M, Moon WK: 18\u00a0F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes. Eur Radiol. 2014, 24: 610-618. 10.1007\/s00330-013-3037-1.","journal-title":"Eur Radiol"},{"key":"4912_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1387\/ijdb.113382aa","volume":"55","author":"A Albergaria","year":"2011","unstructured":"Albergaria A, Ribeiro AS, Vieira AF, Sousa B, Nobre AR, Seruca R, Schmitt F, Paredes J: P-cadherin role in normal breast development and cancer. Int J Dev Biol. 2011, 55: 811-822. 10.1387\/ijdb.113382aa.","journal-title":"Int J Dev Biol"},{"key":"4912_CR19","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1083\/jcb.139.4.1025","volume":"139","author":"GL Radice","year":"1997","unstructured":"Radice GL, Ferreira-Cornwell MC, Robinson SD, Rayburn H, Chodosh LA, Takeichi M, Hynes RO: Precocious mammary gland development in P-cadherin-deficient mice. J Cell Biol. 1997, 139: 1025-1032. 10.1083\/jcb.139.4.1025.","journal-title":"J Cell Biol"},{"key":"4912_CR20","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1002\/stem.182","volume":"27","author":"G Kolle","year":"2009","unstructured":"Kolle G, Ho M, Zhou Q, Chy HS, Krishnan K, Cloonan N, Bertoncello I, Laslett AL, Grimmond SM: Identification of human embryonic stem cell surface markers by combined membrane-polysome translation state array analysis and immunotranscriptional profiling. Stem Cells. 2009, 27: 2446-2456. 10.1002\/stem.182.","journal-title":"Stem Cells"},{"key":"4912_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1006\/dbio.1995.1165","volume":"169","author":"CW Daniel","year":"1995","unstructured":"Daniel CW, Strickland P, Friedmann Y: Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Develop Biol. 1995, 169: 511-519. 10.1006\/dbio.1995.1165.","journal-title":"Develop Biol"},{"key":"4912_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/bcr1774","volume":"9","author":"J Paredes","year":"2007","unstructured":"Paredes J, Correia AL, Ribeiro AS, Albergaria A, Milanezi F, Schmitt FC: P-cadherin expression in breast cancer: a review. Breast Cancer Res. 2007, 9: 214-10.1186\/bcr1774.","journal-title":"Breast Cancer Res"},{"key":"4912_CR23","first-page":"605","volume":"146","author":"J Palacios","year":"1995","unstructured":"Palacios J, Benito N, Pizarro A, Suarez A, Espada J, Cano A, Gamallo C: Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol. 1995, 146: 605-612.","journal-title":"Am J Pathol"},{"key":"4912_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00428-006-0334-y","volume":"450","author":"J Paredes","year":"2007","unstructured":"Paredes J, Lopes N, Milanezi F, Schmitt FC: P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ. Virchows Arch. 2007, 450: 73-80. 10.1007\/s00428-006-0334-y.","journal-title":"Virchows Arch"},{"key":"4912_CR25","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-05-0059","volume":"11","author":"J Paredes","year":"2005","unstructured":"Paredes J, Albergaria A, Oliveira JT, Jeronimo C, Milanezi F, Schmitt FC: P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res. 2005, 11: 5869-5877. 10.1158\/1078-0432.CCR-05-0059.","journal-title":"Clin Cancer Res"},{"key":"4912_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1078\/0344-0338-00338","volume":"198","author":"J Paredes","year":"2002","unstructured":"Paredes J, Milanezi F, Reis-Filho JS, Leitao D, Athanazio D, Schmitt F: Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer?. Pathol Res Pract. 2002, 198: 795-801. 10.1078\/0344-0338-00338.","journal-title":"Pathol Res Pract"},{"key":"4912_CR27","first-page":"963","volume":"25","author":"B Sousa","year":"2010","unstructured":"Sousa B, Paredes J, Milanezi F, Lopes N, Martins D, Dufloth R, Vieira D, Albergaria A, Veronese L, Carneiro V, Carvalho S, Costa JL, Zeferino L, Schmitt F: P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study. Histol Histopathol. 2010, 25: 963-974.","journal-title":"Histol Histopathol"},{"key":"4912_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/onc.2009.338","volume":"29","author":"AS Ribeiro","year":"2010","unstructured":"Ribeiro AS, Albergaria A, Sousa B, Correia AL, Bracke M, Seruca R, Schmitt FC, Paredes J: Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Oncogene. 2010, 29: 392-402. 10.1038\/onc.2009.338.","journal-title":"Oncogene"},{"key":"4912_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/path.4143","volume":"229","author":"AS Ribeiro","year":"2013","unstructured":"Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Soderberg O, Seruca R, Santos MA, Schmitt F, Paredes J: P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. J Pathol. 2013, 229: 705-718. 10.1002\/path.4143.","journal-title":"J Pathol"},{"key":"4912_CR30","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/stem.1075","volume":"30","author":"AF Vieira","year":"2012","unstructured":"Vieira AF, Ricardo S, Ablett MP, Dionisio MR, Mendes N, Albergaria A, Farnie G, Gerhard R, Cameselle-Teijeiro JF, Seruca R, Schmitt F, Clarke RB, Paredes J: P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer. Stem Cells. 2012, 30: 854-864. 10.1002\/stem.1075.","journal-title":"Stem Cells"},{"key":"4912_CR31","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/stem.1662","volume":"32","author":"W Feng","year":"2014","unstructured":"Feng W, Gentles A, Nair RV, Huang M, Lin Y, Lee CY, Cai S, Scheeren FA, Kuo AH, Diehn M: Targeting unique metabolic properties of breast tumor initiating cells. Stem Cells. 2014, 32: 1734-1745. 10.1002\/stem.1662.","journal-title":"Stem Cells"},{"key":"4912_CR32","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/jnci\/djj495","volume":"98","author":"TM Phillips","year":"2006","unstructured":"Phillips TM, McBride WH, Pajonk F: The response of CD24(-\/low)\/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst. 2006, 98: 1777-1785. 10.1093\/jnci\/djj495.","journal-title":"J Natl Cancer Inst"},{"key":"4912_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"4912_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/bioinformatics\/18.2.333","volume":"18","author":"X Messeguer","year":"2002","unstructured":"Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM: PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002, 18: 333-334. 10.1093\/bioinformatics\/18.2.333.","journal-title":"Bioinformatics"},{"key":"4912_CR35","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1093\/nar\/gkg605","volume":"31","author":"D Farre","year":"2003","unstructured":"Farre D, Roset R, Huerta M, Adsuara JE, Rosello L, Alba MM, Messeguer X: Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 2003, 31: 3651-3653. 10.1093\/nar\/gkg605.","journal-title":"Nucleic Acids Res"},{"key":"4912_CR36","doi-asserted-by":"publisher","first-page":"D749","DOI":"10.1093\/nar\/gkt1196","volume":"42","author":"P Flicek","year":"2014","unstructured":"Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, Gil L, Giron CG, Gordon L, Hourlier T, Hunt S, Johnson N, Juettemann T, Kahari AK, Keenan S, Kulesha E, Martin FJ, Maurel T, McLaren WM, Murphy DN, Nag R, Overduin B, Pignatelli M, Pritchard B, Pritchard E, Riat HS, et al: Ensembl 2014. Nucleic Acids Res. 2014, 42: D749-D755. 10.1093\/nar\/gkt1196.","journal-title":"Nucleic Acids Res"},{"key":"4912_CR37","doi-asserted-by":"publisher","first-page":"e20914","DOI":"10.1371\/journal.pone.0020914","volume":"6","author":"S Varum","year":"2011","unstructured":"Varum S, Rodrigues AS, Moura MB, Momcilovic O, Easley CA, Ramalho-Santos J, Van Houten B, Schatten G: Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One. 2011, 6: e20914-10.1371\/journal.pone.0020914.","journal-title":"PLoS One"},{"key":"4912_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/cr.2011.177","volume":"22","author":"AD Panopoulos","year":"2012","unstructured":"Panopoulos AD, Yanes O, Ruiz S, Kida YS, Diep D, Tautenhahn R, Herrerias A, Batchelder EM, Plongthongkum N, Lutz M, Berggren WT, Zhang K, Evans RM, Siuzdak G, Izpisua , Belmonte JC: The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Res. 2012, 22: 168-177. 10.1038\/cr.2011.177.","journal-title":"Cell Res"},{"key":"4912_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cmet.2011.06.011","volume":"14","author":"CD Folmes","year":"2011","unstructured":"Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A: Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 2011, 14: 264-271. 10.1016\/j.cmet.2011.06.011.","journal-title":"Cell Metab"},{"key":"4912_CR40","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1158\/1078-0432.CCR-05-2690","volume":"12","author":"D Generali","year":"2006","unstructured":"Generali D, Berruti A, Brizzi MP, Campo L, Bonardi S, Wigfield S, Bersiga A, Allevi G, Milani M, Aguggini S, Gandolfi V, Dogliotti L, Bottini A, Harris AL, Fox SB: Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res. 2006, 12: 4562-4568. 10.1158\/1078-0432.CCR-05-2690.","journal-title":"Clin Cancer Res"},{"key":"4912_CR41","doi-asserted-by":"publisher","first-page":"8720","DOI":"10.1158\/1078-0432.CCR-04-1235","volume":"10","author":"C Cooper","year":"2004","unstructured":"Cooper C, Liu GY, Niu YL, Santos S, Murphy LC, Watson PH: Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma. Clin Cancer Res. 2004, 10: 8720-8727. 10.1158\/1078-0432.CCR-04-1235.","journal-title":"Clin Cancer Res"},{"key":"4912_CR42","doi-asserted-by":"publisher","first-page":"8309","DOI":"10.1158\/0008-5472.CAN-04-0795","volume":"64","author":"J Paredes","year":"2004","unstructured":"Paredes J, Stove C, Stove V, Milanezi F, Van Marck V, Derycke L, Mareel M, Bracke M, Schmitt F: P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Res. 2004, 64: 8309-8317. 10.1158\/0008-5472.CAN-04-0795.","journal-title":"Cancer Res"},{"key":"4912_CR43","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s10549-009-0565-0","volume":"122","author":"J Gorski","year":"2010","unstructured":"Gorski J, James C, Quinn J, Stewart G, Staunton K, Buckley N, McDyer F, Kennedy R, Wilson R, Mullan P, Harkin D: BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer. Breast Cancer Res Treat. 2010, 122: 721-731. 10.1007\/s10549-009-0565-0.","journal-title":"Breast Cancer Res Treat"},{"key":"4912_CR44","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1128\/MCB.01121-10","volume":"31","author":"Y Lu","year":"2011","unstructured":"Lu Y, Chu A, Turker MS, Glazer PM: Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol Cell Biol. 2011, 31: 3339-3350. 10.1128\/MCB.01121-10.","journal-title":"Mol Cell Biol"},{"key":"4912_CR45","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/sj.bjc.6605287","volume":"101","author":"M Yan","year":"2009","unstructured":"Yan M, Rayoo M, Takano EA, Thorne H, Fox SB: BRCA1 tumours correlate with a HIF-1[alpha] phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression. Br J Cancer. 2009, 101: 1168-1174. 10.1038\/sj.bjc.6605287.","journal-title":"Br J Cancer"},{"key":"4912_CR46","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1158\/1078-0432.CCR-04-2064","volume":"11","author":"JB Arnes","year":"2005","unstructured":"Arnes JB, Brunet JS, Stefansson I, Begin LR, Wong N, Chappuis PO, Akslen LA, Foulkes WD: Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin Cancer Res. 2005, 11: 4003-4011. 10.1158\/1078-0432.CCR-04-2064.","journal-title":"Clin Cancer Res"},{"key":"4912_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2407-13-63","volume":"13","author":"C Gest","year":"2013","unstructured":"Gest C, Joimel U, Huang L, Pritchard LL, Petit A, Dulong C, Buquet C, Hu CQ, Mirshahi P, Laurent M, Fauvel-Lafeve F, Cazin L, Vannier JP, Lu H, Soria J, Li H, Varin R, Soria C: Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines. BMC Cancer. 2013, 13: 63-10.1186\/1471-2407-13-63.","journal-title":"BMC Cancer"},{"key":"4912_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10555-007-9064-0","volume":"26","author":"P Swietach","year":"2007","unstructured":"Swietach P, Vaughan-Jones RD, Harris AL: Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev. 2007, 26: 299-310. 10.1007\/s10555-007-9064-0.","journal-title":"Cancer Metastasis Rev"},{"key":"4912_CR49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.biochi.2004.09.023","volume":"87","author":"EE Gabison","year":"2005","unstructured":"Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S: EMMPRIN\/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie. 2005, 87: 361-368. 10.1016\/j.biochi.2004.09.023.","journal-title":"Biochimie"},{"key":"4912_CR50","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0002-9440(10)64660-3","volume":"158","author":"S Zucker","year":"2001","unstructured":"Zucker S, Hymowitz M, Rollo EE, Mann R, Conner CE, Cao J, Foda HD, Tompkins DC, Toole BP: Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol. 2001, 158: 1921-1928. 10.1016\/S0002-9440(10)64660-3.","journal-title":"Am J Pathol"},{"key":"4912_CR51","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/carcin\/bgs196","volume":"33","author":"X Ke","year":"2012","unstructured":"Ke X, Fei F, Chen Y, Xu L, Zhang Z, Huang Q, Zhang H, Yang H, Chen Z, Xing J: Hypoxia upregulates CD147 through a combined effect of HIF-1alpha and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors. Carcinogenesis. 2012, 33: 1598-1607. 10.1093\/carcin\/bgs196.","journal-title":"Carcinogenesis"},{"key":"4912_CR52","doi-asserted-by":"publisher","first-page":"R6","DOI":"10.1186\/bcr3087","volume":"14","author":"LP Schwab","year":"2012","unstructured":"Schwab LP, Peacock DL, Majumdar D, Ingels JF, Jensen LC, Smith KD, Cushing RC, Seagroves TN: Hypoxia-inducible factor 1alpha promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Breast Cancer Res. 2012, 14: R6-10.1186\/bcr3087.","journal-title":"Breast Cancer Res"},{"key":"4912_CR53","doi-asserted-by":"publisher","first-page":"R94","DOI":"10.1186\/bcr2773","volume":"12","author":"E Louie","year":"2010","unstructured":"Louie E, Nik S, Chen JS, Schmidt M, Song B, Pacson C, Chen XF, Park S, Ju J, Chen EI: Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res. 2010, 12: R94-10.1186\/bcr2773.","journal-title":"Breast Cancer Res"},{"key":"4912_CR54","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1073\/pnas.1018866109","volume":"109","author":"SJ Conley","year":"2012","unstructured":"Conley SJ, Gheordunescu E, Kakarala P, Newman B, Korkaya H, Heath AN, Clouthier SG, Wicha MS: Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci U S A. 2012, 109: 2784-2789. 10.1073\/pnas.1018866109.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4912_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1746-1596-6-73","volume":"6","author":"JP Oliveira-Costa","year":"2011","unstructured":"Oliveira-Costa JP, Zanetti JS, Silveira GG, Soave DF, Oliveira LR, Zorgetto VA, Soares FA, Zucoloto S, Ribeiro-Silva A: Differential expression of HIF-1alpha in CD44\u2009+\u2009CD24-\/low breast ductal carcinomas. Diagn Pathol. 2011, 6: 73-10.1186\/1746-1596-6-73.","journal-title":"Diagn Pathol"},{"key":"4912_CR56","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1038\/onc.2012.550","volume":"32","author":"FE Lock","year":"2013","unstructured":"Lock FE, McDonald PC, Lou Y, Serrano I, Chafe SC, Ostlund C, Aparicio S, Winum JY, Supuran CT, Dedhar S: Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene. 2013, 32: 5210-5219. 10.1038\/onc.2012.550.","journal-title":"Oncogene"},{"key":"4912_CR57","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jcp.2011.090456","volume":"64","author":"S Ricardo","year":"2011","unstructured":"Ricardo S, Vieira AF, Gerhard R, Leitao D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J: Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol. 2011, 64: 937-946. 10.1136\/jcp.2011.090456.","journal-title":"J Clin Pathol"},{"key":"4912_CR58","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009, 458: 780-783. 10.1038\/nature07733.","journal-title":"Nature"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-734\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:01:57Z","timestamp":1630562517000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4912"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-734","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]},"assertion":[{"value":"18 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"734"}}